Picture of Bioethics logo

BOTH Bioethics Income Statement

0.000.00%
us flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro Cap

Annual income statement for Bioethics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue00000
Selling / General / Administrative Expenses
Total Operating Expenses0.0480.0540.070.0750.059
Operating Profit-0.048-0.054-0.07-0.075-0.059
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes-0.064-0.074-0.102-0.119-0.107
Provision for Income Taxes
Net Income After Taxes-0.094-0.107-0.102-0.119-0.107
Net Income Before Extraordinary Items
Extraordinary Items
Net Income-0.064-0.074-0.102-0.119-0.107
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-0.064-0.074-0.102-0.119-0.107
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.008-0.097-0.093-0.105-0.094

Or unlock with your email

Or unlock with your email